Global Rosuvastatin Market

Rosuvastatin Comprehensive Study by Type (High Purity, Low Purity), Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Stores), Form Type (Capsule, Tablet), Dosage (5 mg, 10 mg, 20 mg, 40 mg) Players and Region - Global Market Outlook to 2025

Rosuvastatin Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 3.94%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Rosuvastatin Market Scope
Rosuvastatin is a lipid-lowering drug that belongs to the statin class of medications. It is used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiting the endogenous production of cholesterol in the liver. Rosuvastatin is used along with a proper diet to help lower "bad" cholesterol & fats and raise "good" cholesterol (HDL) in the blood. This drug is commonly known as Crestor and is consumed orally. The developing healthcare infrastructure globally has driven market expansion.

According to AMA, the Global Rosuvastatin market is expected to see growth rate of 3.94%

Research Analyst at AMA estimates that Asia Pacific Players will contribute to the maximum growth of Global Rosuvastatin market throughout the predicted period.

AstraZeneca plc (United Kingdom), Teva Pharmaceutical Industries Ltd. (Israel), MSN Laboratories Private Limited (India), Cadila Pharmaceuticals (India), LGM Pharma LLC (United States), Changzhou Pharmaceutical Factory (China), Zhejiang Jingxin Pharmaceutical Co. Ltd. (China), Hec Pharma Co., Ltd. (China), Lunan Pharmaceutical Group (China), Lianyungang Runzhong Pharmaceutical Co.,Ltd.(China), Shandong bechem chemical co., ltd (China), CTX Life Sciences Pvt. Ltd. (India), Watson Labs, Inc. (India), Torrent Pharma Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), Sandoz (Germany), Aurobindo Pharma Limited (India) and Apotex Inc. (Canada) are some of the key players that are part of study coverage.

Segmentation Overview
The study have segmented the market of Global Rosuvastatin market by Type (High Purity and Low Purity) and Region with country level break-up.

On the basis of geography, the market of Rosuvastatin has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Large Patient Pool In Asia Pacific Region

Market Growth Drivers:
Increasing Use for Prevention of Cardiovascular Disease:” Rosuvastatin is one of the two most commonly used statins and is more effective low-density lipoproteins (LDL) (known as bad cholesterol). It is majorly used to reduce mortality, cardiac events and improve quality of life.” and Prevalence of Obesity

Restraints:
Side Effects of Rosuvastatin and Lack of Medical Awareness

Opportunities:
Preference for Non-Surgical Treatment and The Rise in the Awareness Regarding Healthcare




Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Rosuvastatin Providers, Raw Material Suppliers, Rosuvastatin Distributors/Traders/Suppliers, Government Regulatory and Research Organizations and End-Users

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Type
  • High Purity
  • Low Purity
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Stores

By Form Type
  • Capsule
  • Tablet

By Dosage
  • 5 mg
  • 10 mg
  • 20 mg
  • 40 mg

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Use for Prevention of Cardiovascular Disease:” Rosuvastatin is one of the two most commonly used statins and is more effective low-density lipoproteins (LDL) (known as bad cholesterol). It is majorly used to reduce mortality, cardiac events and improve quality of life.”
      • 3.2.2. Prevalence of Obesity
    • 3.3. Market Trends
      • 3.3.1. Large Patient Pool In Asia Pacific Region
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Rosuvastatin, by Type, Distribution Channel, Form Type, Dosage and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Rosuvastatin (Value)
      • 5.2.1. Global Rosuvastatin by: Type (Value)
        • 5.2.1.1. High Purity
        • 5.2.1.2. Low Purity
      • 5.2.2. Global Rosuvastatin by: Distribution Channel (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies & Drug Stores
        • 5.2.2.3. Online Stores
      • 5.2.3. Global Rosuvastatin by: Form Type (Value)
        • 5.2.3.1. Capsule
        • 5.2.3.2. Tablet
      • 5.2.4. Global Rosuvastatin by: Dosage (Value)
        • 5.2.4.1. 5 mg
        • 5.2.4.2. 10 mg
        • 5.2.4.3. 20 mg
        • 5.2.4.4. 40 mg
      • 5.2.5. Global Rosuvastatin Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Rosuvastatin (Volume)
      • 5.3.1. Global Rosuvastatin by: Type (Volume)
        • 5.3.1.1. High Purity
        • 5.3.1.2. Low Purity
      • 5.3.2. Global Rosuvastatin by: Distribution Channel (Volume)
        • 5.3.2.1. Hospital Pharmacies
        • 5.3.2.2. Retail Pharmacies & Drug Stores
        • 5.3.2.3. Online Stores
      • 5.3.3. Global Rosuvastatin by: Form Type (Volume)
        • 5.3.3.1. Capsule
        • 5.3.3.2. Tablet
      • 5.3.4. Global Rosuvastatin by: Dosage (Volume)
        • 5.3.4.1. 5 mg
        • 5.3.4.2. 10 mg
        • 5.3.4.3. 20 mg
        • 5.3.4.4. 40 mg
      • 5.3.5. Global Rosuvastatin Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Rosuvastatin (Price)
      • 5.4.1. Global Rosuvastatin by: Type (Price)
  • 6. Rosuvastatin: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AstraZeneca plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. MSN Laboratories Private Limited (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cadila Pharmaceuticals (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. LGM Pharma LLC (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Changzhou Pharmaceutical Factory (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Zhejiang Jingxin Pharmaceutical Co. Ltd. (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hec Pharma Co., Ltd. (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lunan Pharmaceutical Group (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Lianyungang Runzhong Pharmaceutical Co.,Ltd.(China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Shandong bechem chemical co., ltd (China)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. CTX Life Sciences Pvt. Ltd. (India)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Watson Labs, Inc. (India)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Torrent Pharma Ltd. (India)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Sun Pharmaceutical Industries Ltd. (India)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Sandoz (Germany)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Aurobindo Pharma Limited (India)
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
      • 6.4.18. Apotex Inc. (Canada)
        • 6.4.18.1. Business Overview
        • 6.4.18.2. Products/Services Offerings
        • 6.4.18.3. Financial Analysis
        • 6.4.18.4. SWOT Analysis
  • 7. Global Rosuvastatin Sale, by Type, Distribution Channel, Form Type, Dosage and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Rosuvastatin (Value)
      • 7.2.1. Global Rosuvastatin by: Type (Value)
        • 7.2.1.1. High Purity
        • 7.2.1.2. Low Purity
      • 7.2.2. Global Rosuvastatin by: Distribution Channel (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies & Drug Stores
        • 7.2.2.3. Online Stores
      • 7.2.3. Global Rosuvastatin by: Form Type (Value)
        • 7.2.3.1. Capsule
        • 7.2.3.2. Tablet
      • 7.2.4. Global Rosuvastatin by: Dosage (Value)
        • 7.2.4.1. 5 mg
        • 7.2.4.2. 10 mg
        • 7.2.4.3. 20 mg
        • 7.2.4.4. 40 mg
      • 7.2.5. Global Rosuvastatin Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Rosuvastatin (Volume)
      • 7.3.1. Global Rosuvastatin by: Type (Volume)
        • 7.3.1.1. High Purity
        • 7.3.1.2. Low Purity
      • 7.3.2. Global Rosuvastatin by: Distribution Channel (Volume)
        • 7.3.2.1. Hospital Pharmacies
        • 7.3.2.2. Retail Pharmacies & Drug Stores
        • 7.3.2.3. Online Stores
      • 7.3.3. Global Rosuvastatin by: Form Type (Volume)
        • 7.3.3.1. Capsule
        • 7.3.3.2. Tablet
      • 7.3.4. Global Rosuvastatin by: Dosage (Volume)
        • 7.3.4.1. 5 mg
        • 7.3.4.2. 10 mg
        • 7.3.4.3. 20 mg
        • 7.3.4.4. 40 mg
      • 7.3.5. Global Rosuvastatin Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Rosuvastatin (Price)
      • 7.4.1. Global Rosuvastatin by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Rosuvastatin: by Type(USD Million)
  • Table 2. Rosuvastatin High Purity , by Region USD Million (2016-2021)
  • Table 3. Rosuvastatin Low Purity , by Region USD Million (2016-2021)
  • Table 4. Rosuvastatin: by Distribution Channel(USD Million)
  • Table 5. Rosuvastatin Hospital Pharmacies , by Region USD Million (2016-2021)
  • Table 6. Rosuvastatin Retail Pharmacies & Drug Stores , by Region USD Million (2016-2021)
  • Table 7. Rosuvastatin Online Stores , by Region USD Million (2016-2021)
  • Table 8. Rosuvastatin: by Form Type(USD Million)
  • Table 9. Rosuvastatin Capsule , by Region USD Million (2016-2021)
  • Table 10. Rosuvastatin Tablet , by Region USD Million (2016-2021)
  • Table 11. Rosuvastatin: by Dosage(USD Million)
  • Table 12. Rosuvastatin 5 mg , by Region USD Million (2016-2021)
  • Table 13. Rosuvastatin 10 mg , by Region USD Million (2016-2021)
  • Table 14. Rosuvastatin 20 mg , by Region USD Million (2016-2021)
  • Table 15. Rosuvastatin 40 mg , by Region USD Million (2016-2021)
  • Table 16. South America Rosuvastatin, by Country USD Million (2016-2021)
  • Table 17. South America Rosuvastatin, by Type USD Million (2016-2021)
  • Table 18. South America Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 19. South America Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 20. South America Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 21. Brazil Rosuvastatin, by Type USD Million (2016-2021)
  • Table 22. Brazil Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 23. Brazil Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 24. Brazil Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 25. Argentina Rosuvastatin, by Type USD Million (2016-2021)
  • Table 26. Argentina Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 27. Argentina Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 28. Argentina Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 29. Rest of South America Rosuvastatin, by Type USD Million (2016-2021)
  • Table 30. Rest of South America Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 31. Rest of South America Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 32. Rest of South America Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 33. Asia Pacific Rosuvastatin, by Country USD Million (2016-2021)
  • Table 34. Asia Pacific Rosuvastatin, by Type USD Million (2016-2021)
  • Table 35. Asia Pacific Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 36. Asia Pacific Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 37. Asia Pacific Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 38. China Rosuvastatin, by Type USD Million (2016-2021)
  • Table 39. China Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 40. China Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 41. China Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 42. Japan Rosuvastatin, by Type USD Million (2016-2021)
  • Table 43. Japan Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 44. Japan Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 45. Japan Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 46. India Rosuvastatin, by Type USD Million (2016-2021)
  • Table 47. India Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 48. India Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 49. India Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 50. South Korea Rosuvastatin, by Type USD Million (2016-2021)
  • Table 51. South Korea Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 52. South Korea Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 53. South Korea Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 54. Taiwan Rosuvastatin, by Type USD Million (2016-2021)
  • Table 55. Taiwan Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 56. Taiwan Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 57. Taiwan Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 58. Australia Rosuvastatin, by Type USD Million (2016-2021)
  • Table 59. Australia Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 60. Australia Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 61. Australia Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific Rosuvastatin, by Type USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 66. Europe Rosuvastatin, by Country USD Million (2016-2021)
  • Table 67. Europe Rosuvastatin, by Type USD Million (2016-2021)
  • Table 68. Europe Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 69. Europe Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 70. Europe Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 71. Germany Rosuvastatin, by Type USD Million (2016-2021)
  • Table 72. Germany Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 73. Germany Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 74. Germany Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 75. France Rosuvastatin, by Type USD Million (2016-2021)
  • Table 76. France Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 77. France Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 78. France Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 79. Italy Rosuvastatin, by Type USD Million (2016-2021)
  • Table 80. Italy Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 81. Italy Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 82. Italy Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 83. United Kingdom Rosuvastatin, by Type USD Million (2016-2021)
  • Table 84. United Kingdom Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 85. United Kingdom Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 86. United Kingdom Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 87. Netherlands Rosuvastatin, by Type USD Million (2016-2021)
  • Table 88. Netherlands Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 89. Netherlands Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 90. Netherlands Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 91. Rest of Europe Rosuvastatin, by Type USD Million (2016-2021)
  • Table 92. Rest of Europe Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 93. Rest of Europe Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 94. Rest of Europe Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 95. MEA Rosuvastatin, by Country USD Million (2016-2021)
  • Table 96. MEA Rosuvastatin, by Type USD Million (2016-2021)
  • Table 97. MEA Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 98. MEA Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 99. MEA Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 100. Middle East Rosuvastatin, by Type USD Million (2016-2021)
  • Table 101. Middle East Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 102. Middle East Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 103. Middle East Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 104. Africa Rosuvastatin, by Type USD Million (2016-2021)
  • Table 105. Africa Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 106. Africa Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 107. Africa Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 108. North America Rosuvastatin, by Country USD Million (2016-2021)
  • Table 109. North America Rosuvastatin, by Type USD Million (2016-2021)
  • Table 110. North America Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 111. North America Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 112. North America Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 113. United States Rosuvastatin, by Type USD Million (2016-2021)
  • Table 114. United States Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 115. United States Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 116. United States Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 117. Canada Rosuvastatin, by Type USD Million (2016-2021)
  • Table 118. Canada Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 119. Canada Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 120. Canada Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 121. Mexico Rosuvastatin, by Type USD Million (2016-2021)
  • Table 122. Mexico Rosuvastatin, by Distribution Channel USD Million (2016-2021)
  • Table 123. Mexico Rosuvastatin, by Form Type USD Million (2016-2021)
  • Table 124. Mexico Rosuvastatin, by Dosage USD Million (2016-2021)
  • Table 125. Rosuvastatin Sales: by Type(Tons)
  • Table 126. Rosuvastatin Sales High Purity , by Region Tons (2016-2021)
  • Table 127. Rosuvastatin Sales Low Purity , by Region Tons (2016-2021)
  • Table 128. Rosuvastatin Sales: by Distribution Channel(Tons)
  • Table 129. Rosuvastatin Sales Hospital Pharmacies , by Region Tons (2016-2021)
  • Table 130. Rosuvastatin Sales Retail Pharmacies & Drug Stores , by Region Tons (2016-2021)
  • Table 131. Rosuvastatin Sales Online Stores , by Region Tons (2016-2021)
  • Table 132. Rosuvastatin Sales: by Form Type(Tons)
  • Table 133. Rosuvastatin Sales Capsule , by Region Tons (2016-2021)
  • Table 134. Rosuvastatin Sales Tablet , by Region Tons (2016-2021)
  • Table 135. Rosuvastatin Sales: by Dosage(Tons)
  • Table 136. Rosuvastatin Sales 5 mg , by Region Tons (2016-2021)
  • Table 137. Rosuvastatin Sales 10 mg , by Region Tons (2016-2021)
  • Table 138. Rosuvastatin Sales 20 mg , by Region Tons (2016-2021)
  • Table 139. Rosuvastatin Sales 40 mg , by Region Tons (2016-2021)
  • Table 140. South America Rosuvastatin Sales, by Country Tons (2016-2021)
  • Table 141. South America Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 142. South America Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 143. South America Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 144. South America Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 145. Brazil Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 146. Brazil Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 147. Brazil Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 148. Brazil Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 149. Argentina Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 150. Argentina Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 151. Argentina Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 152. Argentina Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 153. Rest of South America Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 154. Rest of South America Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 155. Rest of South America Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 156. Rest of South America Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 157. Asia Pacific Rosuvastatin Sales, by Country Tons (2016-2021)
  • Table 158. Asia Pacific Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 159. Asia Pacific Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 160. Asia Pacific Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 161. Asia Pacific Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 162. China Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 163. China Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 164. China Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 165. China Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 166. Japan Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 167. Japan Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 168. Japan Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 169. Japan Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 170. India Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 171. India Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 172. India Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 173. India Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 174. South Korea Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 175. South Korea Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 176. South Korea Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 177. South Korea Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 178. Taiwan Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 179. Taiwan Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 180. Taiwan Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 181. Taiwan Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 182. Australia Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 183. Australia Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 184. Australia Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 185. Australia Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 186. Rest of Asia-Pacific Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 187. Rest of Asia-Pacific Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 188. Rest of Asia-Pacific Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 189. Rest of Asia-Pacific Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 190. Europe Rosuvastatin Sales, by Country Tons (2016-2021)
  • Table 191. Europe Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 192. Europe Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 193. Europe Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 194. Europe Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 195. Germany Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 196. Germany Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 197. Germany Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 198. Germany Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 199. France Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 200. France Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 201. France Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 202. France Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 203. Italy Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 204. Italy Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 205. Italy Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 206. Italy Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 207. United Kingdom Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 208. United Kingdom Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 209. United Kingdom Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 210. United Kingdom Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 211. Netherlands Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 212. Netherlands Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 213. Netherlands Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 214. Netherlands Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 215. Rest of Europe Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 216. Rest of Europe Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 217. Rest of Europe Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 218. Rest of Europe Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 219. MEA Rosuvastatin Sales, by Country Tons (2016-2021)
  • Table 220. MEA Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 221. MEA Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 222. MEA Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 223. MEA Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 224. Middle East Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 225. Middle East Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 226. Middle East Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 227. Middle East Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 228. Africa Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 229. Africa Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 230. Africa Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 231. Africa Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 232. North America Rosuvastatin Sales, by Country Tons (2016-2021)
  • Table 233. North America Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 234. North America Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 235. North America Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 236. North America Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 237. United States Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 238. United States Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 239. United States Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 240. United States Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 241. Canada Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 242. Canada Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 243. Canada Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 244. Canada Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 245. Mexico Rosuvastatin Sales, by Type Tons (2016-2021)
  • Table 246. Mexico Rosuvastatin Sales, by Distribution Channel Tons (2016-2021)
  • Table 247. Mexico Rosuvastatin Sales, by Form Type Tons (2016-2021)
  • Table 248. Mexico Rosuvastatin Sales, by Dosage Tons (2016-2021)
  • Table 249. Rosuvastatin: by Type(USD/Units)
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Rosuvastatin: by Type(USD Million)
  • Table 269. Rosuvastatin High Purity , by Region USD Million (2022-2027)
  • Table 270. Rosuvastatin Low Purity , by Region USD Million (2022-2027)
  • Table 271. Rosuvastatin: by Distribution Channel(USD Million)
  • Table 272. Rosuvastatin Hospital Pharmacies , by Region USD Million (2022-2027)
  • Table 273. Rosuvastatin Retail Pharmacies & Drug Stores , by Region USD Million (2022-2027)
  • Table 274. Rosuvastatin Online Stores , by Region USD Million (2022-2027)
  • Table 275. Rosuvastatin: by Form Type(USD Million)
  • Table 276. Rosuvastatin Capsule , by Region USD Million (2022-2027)
  • Table 277. Rosuvastatin Tablet , by Region USD Million (2022-2027)
  • Table 278. Rosuvastatin: by Dosage(USD Million)
  • Table 279. Rosuvastatin 5 mg , by Region USD Million (2022-2027)
  • Table 280. Rosuvastatin 10 mg , by Region USD Million (2022-2027)
  • Table 281. Rosuvastatin 20 mg , by Region USD Million (2022-2027)
  • Table 282. Rosuvastatin 40 mg , by Region USD Million (2022-2027)
  • Table 283. South America Rosuvastatin, by Country USD Million (2022-2027)
  • Table 284. South America Rosuvastatin, by Type USD Million (2022-2027)
  • Table 285. South America Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 286. South America Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 287. South America Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 288. Brazil Rosuvastatin, by Type USD Million (2022-2027)
  • Table 289. Brazil Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 290. Brazil Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 291. Brazil Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 292. Argentina Rosuvastatin, by Type USD Million (2022-2027)
  • Table 293. Argentina Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 294. Argentina Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 295. Argentina Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 296. Rest of South America Rosuvastatin, by Type USD Million (2022-2027)
  • Table 297. Rest of South America Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 298. Rest of South America Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 299. Rest of South America Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 300. Asia Pacific Rosuvastatin, by Country USD Million (2022-2027)
  • Table 301. Asia Pacific Rosuvastatin, by Type USD Million (2022-2027)
  • Table 302. Asia Pacific Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 303. Asia Pacific Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 304. Asia Pacific Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 305. China Rosuvastatin, by Type USD Million (2022-2027)
  • Table 306. China Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 307. China Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 308. China Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 309. Japan Rosuvastatin, by Type USD Million (2022-2027)
  • Table 310. Japan Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 311. Japan Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 312. Japan Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 313. India Rosuvastatin, by Type USD Million (2022-2027)
  • Table 314. India Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 315. India Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 316. India Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 317. South Korea Rosuvastatin, by Type USD Million (2022-2027)
  • Table 318. South Korea Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 319. South Korea Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 320. South Korea Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 321. Taiwan Rosuvastatin, by Type USD Million (2022-2027)
  • Table 322. Taiwan Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 323. Taiwan Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 324. Taiwan Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 325. Australia Rosuvastatin, by Type USD Million (2022-2027)
  • Table 326. Australia Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 327. Australia Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 328. Australia Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 329. Rest of Asia-Pacific Rosuvastatin, by Type USD Million (2022-2027)
  • Table 330. Rest of Asia-Pacific Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 331. Rest of Asia-Pacific Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 332. Rest of Asia-Pacific Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 333. Europe Rosuvastatin, by Country USD Million (2022-2027)
  • Table 334. Europe Rosuvastatin, by Type USD Million (2022-2027)
  • Table 335. Europe Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 336. Europe Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 337. Europe Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 338. Germany Rosuvastatin, by Type USD Million (2022-2027)
  • Table 339. Germany Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 340. Germany Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 341. Germany Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 342. France Rosuvastatin, by Type USD Million (2022-2027)
  • Table 343. France Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 344. France Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 345. France Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 346. Italy Rosuvastatin, by Type USD Million (2022-2027)
  • Table 347. Italy Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 348. Italy Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 349. Italy Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 350. United Kingdom Rosuvastatin, by Type USD Million (2022-2027)
  • Table 351. United Kingdom Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 352. United Kingdom Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 353. United Kingdom Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 354. Netherlands Rosuvastatin, by Type USD Million (2022-2027)
  • Table 355. Netherlands Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 356. Netherlands Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 357. Netherlands Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 358. Rest of Europe Rosuvastatin, by Type USD Million (2022-2027)
  • Table 359. Rest of Europe Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 360. Rest of Europe Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 361. Rest of Europe Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 362. MEA Rosuvastatin, by Country USD Million (2022-2027)
  • Table 363. MEA Rosuvastatin, by Type USD Million (2022-2027)
  • Table 364. MEA Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 365. MEA Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 366. MEA Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 367. Middle East Rosuvastatin, by Type USD Million (2022-2027)
  • Table 368. Middle East Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 369. Middle East Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 370. Middle East Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 371. Africa Rosuvastatin, by Type USD Million (2022-2027)
  • Table 372. Africa Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 373. Africa Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 374. Africa Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 375. North America Rosuvastatin, by Country USD Million (2022-2027)
  • Table 376. North America Rosuvastatin, by Type USD Million (2022-2027)
  • Table 377. North America Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 378. North America Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 379. North America Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 380. United States Rosuvastatin, by Type USD Million (2022-2027)
  • Table 381. United States Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 382. United States Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 383. United States Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 384. Canada Rosuvastatin, by Type USD Million (2022-2027)
  • Table 385. Canada Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 386. Canada Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 387. Canada Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 388. Mexico Rosuvastatin, by Type USD Million (2022-2027)
  • Table 389. Mexico Rosuvastatin, by Distribution Channel USD Million (2022-2027)
  • Table 390. Mexico Rosuvastatin, by Form Type USD Million (2022-2027)
  • Table 391. Mexico Rosuvastatin, by Dosage USD Million (2022-2027)
  • Table 392. Rosuvastatin Sales: by Type(Tons)
  • Table 393. Rosuvastatin Sales High Purity , by Region Tons (2022-2027)
  • Table 394. Rosuvastatin Sales Low Purity , by Region Tons (2022-2027)
  • Table 395. Rosuvastatin Sales: by Distribution Channel(Tons)
  • Table 396. Rosuvastatin Sales Hospital Pharmacies , by Region Tons (2022-2027)
  • Table 397. Rosuvastatin Sales Retail Pharmacies & Drug Stores , by Region Tons (2022-2027)
  • Table 398. Rosuvastatin Sales Online Stores , by Region Tons (2022-2027)
  • Table 399. Rosuvastatin Sales: by Form Type(Tons)
  • Table 400. Rosuvastatin Sales Capsule , by Region Tons (2022-2027)
  • Table 401. Rosuvastatin Sales Tablet , by Region Tons (2022-2027)
  • Table 402. Rosuvastatin Sales: by Dosage(Tons)
  • Table 403. Rosuvastatin Sales 5 mg , by Region Tons (2022-2027)
  • Table 404. Rosuvastatin Sales 10 mg , by Region Tons (2022-2027)
  • Table 405. Rosuvastatin Sales 20 mg , by Region Tons (2022-2027)
  • Table 406. Rosuvastatin Sales 40 mg , by Region Tons (2022-2027)
  • Table 407. South America Rosuvastatin Sales, by Country Tons (2022-2027)
  • Table 408. South America Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 409. South America Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 410. South America Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 411. South America Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 412. Brazil Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 413. Brazil Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 414. Brazil Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 415. Brazil Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 416. Argentina Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 417. Argentina Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 418. Argentina Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 419. Argentina Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 420. Rest of South America Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 421. Rest of South America Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 422. Rest of South America Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 423. Rest of South America Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 424. Asia Pacific Rosuvastatin Sales, by Country Tons (2022-2027)
  • Table 425. Asia Pacific Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 426. Asia Pacific Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 427. Asia Pacific Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 428. Asia Pacific Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 429. China Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 430. China Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 431. China Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 432. China Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 433. Japan Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 434. Japan Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 435. Japan Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 436. Japan Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 437. India Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 438. India Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 439. India Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 440. India Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 441. South Korea Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 442. South Korea Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 443. South Korea Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 444. South Korea Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 445. Taiwan Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 446. Taiwan Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 447. Taiwan Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 448. Taiwan Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 449. Australia Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 450. Australia Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 451. Australia Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 452. Australia Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 453. Rest of Asia-Pacific Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 454. Rest of Asia-Pacific Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 455. Rest of Asia-Pacific Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 456. Rest of Asia-Pacific Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 457. Europe Rosuvastatin Sales, by Country Tons (2022-2027)
  • Table 458. Europe Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 459. Europe Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 460. Europe Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 461. Europe Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 462. Germany Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 463. Germany Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 464. Germany Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 465. Germany Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 466. France Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 467. France Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 468. France Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 469. France Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 470. Italy Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 471. Italy Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 472. Italy Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 473. Italy Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 474. United Kingdom Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 475. United Kingdom Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 476. United Kingdom Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 477. United Kingdom Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 478. Netherlands Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 479. Netherlands Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 480. Netherlands Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 481. Netherlands Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 482. Rest of Europe Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 483. Rest of Europe Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 484. Rest of Europe Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 485. Rest of Europe Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 486. MEA Rosuvastatin Sales, by Country Tons (2022-2027)
  • Table 487. MEA Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 488. MEA Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 489. MEA Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 490. MEA Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 491. Middle East Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 492. Middle East Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 493. Middle East Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 494. Middle East Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 495. Africa Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 496. Africa Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 497. Africa Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 498. Africa Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 499. North America Rosuvastatin Sales, by Country Tons (2022-2027)
  • Table 500. North America Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 501. North America Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 502. North America Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 503. North America Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 504. United States Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 505. United States Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 506. United States Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 507. United States Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 508. Canada Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 509. Canada Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 510. Canada Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 511. Canada Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 512. Mexico Rosuvastatin Sales, by Type Tons (2022-2027)
  • Table 513. Mexico Rosuvastatin Sales, by Distribution Channel Tons (2022-2027)
  • Table 514. Mexico Rosuvastatin Sales, by Form Type Tons (2022-2027)
  • Table 515. Mexico Rosuvastatin Sales, by Dosage Tons (2022-2027)
  • Table 516. Rosuvastatin: by Type(USD/Units)
  • Table 517. Research Programs/Design for This Report
  • Table 518. Key Data Information from Secondary Sources
  • Table 519. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Rosuvastatin: by Type USD Million (2016-2021)
  • Figure 5. Global Rosuvastatin: by Distribution Channel USD Million (2016-2021)
  • Figure 6. Global Rosuvastatin: by Form Type USD Million (2016-2021)
  • Figure 7. Global Rosuvastatin: by Dosage USD Million (2016-2021)
  • Figure 8. South America Rosuvastatin Share (%), by Country
  • Figure 9. Asia Pacific Rosuvastatin Share (%), by Country
  • Figure 10. Europe Rosuvastatin Share (%), by Country
  • Figure 11. MEA Rosuvastatin Share (%), by Country
  • Figure 12. North America Rosuvastatin Share (%), by Country
  • Figure 13. Global Rosuvastatin: by Type Tons (2016-2021)
  • Figure 14. Global Rosuvastatin: by Distribution Channel Tons (2016-2021)
  • Figure 15. Global Rosuvastatin: by Form Type Tons (2016-2021)
  • Figure 16. Global Rosuvastatin: by Dosage Tons (2016-2021)
  • Figure 17. South America Rosuvastatin Share (%), by Country
  • Figure 18. Asia Pacific Rosuvastatin Share (%), by Country
  • Figure 19. Europe Rosuvastatin Share (%), by Country
  • Figure 20. MEA Rosuvastatin Share (%), by Country
  • Figure 21. North America Rosuvastatin Share (%), by Country
  • Figure 22. Global Rosuvastatin: by Type USD/Units (2016-2021)
  • Figure 23. Global Rosuvastatin share by Players 2021 (%)
  • Figure 24. Global Rosuvastatin share by Players (Top 3) 2021(%)
  • Figure 25. Global Rosuvastatin share by Players (Top 5) 2021(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. AstraZeneca plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. AstraZeneca plc (United Kingdom) Revenue: by Geography 2021
  • Figure 29. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 30. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2021
  • Figure 31. MSN Laboratories Private Limited (India) Revenue, Net Income and Gross profit
  • Figure 32. MSN Laboratories Private Limited (India) Revenue: by Geography 2021
  • Figure 33. Cadila Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 34. Cadila Pharmaceuticals (India) Revenue: by Geography 2021
  • Figure 35. LGM Pharma LLC (United States) Revenue, Net Income and Gross profit
  • Figure 36. LGM Pharma LLC (United States) Revenue: by Geography 2021
  • Figure 37. Changzhou Pharmaceutical Factory (China) Revenue, Net Income and Gross profit
  • Figure 38. Changzhou Pharmaceutical Factory (China) Revenue: by Geography 2021
  • Figure 39. Zhejiang Jingxin Pharmaceutical Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 40. Zhejiang Jingxin Pharmaceutical Co. Ltd. (China) Revenue: by Geography 2021
  • Figure 41. Hec Pharma Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 42. Hec Pharma Co., Ltd. (China) Revenue: by Geography 2021
  • Figure 43. Lunan Pharmaceutical Group (China) Revenue, Net Income and Gross profit
  • Figure 44. Lunan Pharmaceutical Group (China) Revenue: by Geography 2021
  • Figure 45. Lianyungang Runzhong Pharmaceutical Co.,Ltd.(China) Revenue, Net Income and Gross profit
  • Figure 46. Lianyungang Runzhong Pharmaceutical Co.,Ltd.(China) Revenue: by Geography 2021
  • Figure 47. Shandong bechem chemical co., ltd (China) Revenue, Net Income and Gross profit
  • Figure 48. Shandong bechem chemical co., ltd (China) Revenue: by Geography 2021
  • Figure 49. CTX Life Sciences Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 50. CTX Life Sciences Pvt. Ltd. (India) Revenue: by Geography 2021
  • Figure 51. Watson Labs, Inc. (India) Revenue, Net Income and Gross profit
  • Figure 52. Watson Labs, Inc. (India) Revenue: by Geography 2021
  • Figure 53. Torrent Pharma Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 54. Torrent Pharma Ltd. (India) Revenue: by Geography 2021
  • Figure 55. Sun Pharmaceutical Industries Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 56. Sun Pharmaceutical Industries Ltd. (India) Revenue: by Geography 2021
  • Figure 57. Sandoz (Germany) Revenue, Net Income and Gross profit
  • Figure 58. Sandoz (Germany) Revenue: by Geography 2021
  • Figure 59. Aurobindo Pharma Limited (India) Revenue, Net Income and Gross profit
  • Figure 60. Aurobindo Pharma Limited (India) Revenue: by Geography 2021
  • Figure 61. Apotex Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 62. Apotex Inc. (Canada) Revenue: by Geography 2021
  • Figure 63. Global Rosuvastatin: by Type USD Million (2022-2027)
  • Figure 64. Global Rosuvastatin: by Distribution Channel USD Million (2022-2027)
  • Figure 65. Global Rosuvastatin: by Form Type USD Million (2022-2027)
  • Figure 66. Global Rosuvastatin: by Dosage USD Million (2022-2027)
  • Figure 67. South America Rosuvastatin Share (%), by Country
  • Figure 68. Asia Pacific Rosuvastatin Share (%), by Country
  • Figure 69. Europe Rosuvastatin Share (%), by Country
  • Figure 70. MEA Rosuvastatin Share (%), by Country
  • Figure 71. North America Rosuvastatin Share (%), by Country
  • Figure 72. Global Rosuvastatin: by Type Tons (2022-2027)
  • Figure 73. Global Rosuvastatin: by Distribution Channel Tons (2022-2027)
  • Figure 74. Global Rosuvastatin: by Form Type Tons (2022-2027)
  • Figure 75. Global Rosuvastatin: by Dosage Tons (2022-2027)
  • Figure 76. South America Rosuvastatin Share (%), by Country
  • Figure 77. Asia Pacific Rosuvastatin Share (%), by Country
  • Figure 78. Europe Rosuvastatin Share (%), by Country
  • Figure 79. MEA Rosuvastatin Share (%), by Country
  • Figure 80. North America Rosuvastatin Share (%), by Country
  • Figure 81. Global Rosuvastatin: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • AstraZeneca plc (United Kingdom)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • MSN Laboratories Private Limited (India)
  • Cadila Pharmaceuticals (India)
  • LGM Pharma LLC (United States)
  • Changzhou Pharmaceutical Factory (China)
  • Zhejiang Jingxin Pharmaceutical Co. Ltd. (China)
  • Hec Pharma Co., Ltd. (China)
  • Lunan Pharmaceutical Group (China)
  • Lianyungang Runzhong Pharmaceutical Co.,Ltd.(China)
  • Shandong bechem chemical co., ltd (China)
  • CTX Life Sciences Pvt. Ltd. (India)
  • Watson Labs, Inc. (India)
  • Torrent Pharma Ltd. (India)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Sandoz (Germany)
  • Aurobindo Pharma Limited (India)
  • Apotex Inc. (Canada)
Select User Access Type

Key Highlights of Report


Feb 2020 222 Pages 88 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Rosuvastatin Market Quantitative research analysis
Global Rosuvastatin Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Rosuvastatin study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
The Rosuvastatin Market is gaining popularity and expected to see strong valuation by 2027 .
According to AMA, the Global Rosuvastatin market is expected to see growth rate of xx%.
The Rosuvastatin market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Rosuvastatin Market Report?

Have a Query? Click Here

Other Related Reports

Xeloda Comprehensive Study by Application (Colon Cancer, Rectal Cancer, Breast Cancer, Gastric Cancer, Others), Strength (500mg, 100mg) Players and Region - Global Market Outlook to 2026
$ 3500
Wound Cleanser Solutions Comprehensive Study by Type (Saline, Polyhexethylene biguanide (PHMB), Hypochlorous Acid (HOCl), Chlorhexidine solution, Acetic acid, Superoxidised solution, Hydrogen peroxid...
$ 3650
Feed Phytogenics Comprehensive Study by Product Type (Essential oils, Herbs & spices, Oleoresins, Others), Livestock (Poultry, Swine, Ruminant, Aquatic, Equine, Others), Function (Palatability Enha...
$ 3650
Streptokinase Comprehensive Study by Application (Myocardial Infarction (MI), Deep vein thrombosis, Pulmonary embolism, Others), Way of ordering (Walk-in, Application, Online) Players and Region - Gl...
$ 3500
Anti-Aging Drugs Comprehensive Study by Application (Skin and Hair, Skeletal and Muscles, Age Related Disorders, Others), Therapy (Homeopathic, Allopathic), Drug Class (Serums and Supplement, Antiox...
$ 3350
Animal Health Comprehensive Study by Type (Vaccines (Live Attenuated Vaccine, DNA Vaccines, Recombinant Vaccines and Inactivated Vaccines ), Feed Additives (Nutritional and Medicinal), Pharmaceutical...
$ 3750